Wall Street Payday: The banks on the massive AbbVie-Allergan deal stand to make $183 million
|06/26/2019||Posted by BusinessMediaguide.Com under General World News||
- AbbVie said on Tuesday that it’s buying Botox-maker Allergan in a $63 billion deal.
- The deal could generate as much as $183 million in fees for the banks that worked on the deal, according to an estimate from Dealogic.
- That includes JPMorgan, which represented Allergan, Morgan Stanley, which was the lead adviser for AbbVie, and PJT Partners, a boutique investment bank that worked with AbbVie as well.
- Click here for more BI Prime stories.
AbbVie’s proposed $63 billion takeover of Botox-maker Allergan could bring a big payday for the bankers involved in the megamerger.